AKBA

Akebia Therapeutics INC

-$48.7M

Net Activity

Institutions Holding

172

Popularity Rank

#3259

Avg Weight

0.01%

Total Value

$141.7M

Ownership Trend

172 institutions currently hold AKBA, with 71 net buyers and 83 net sellers this quarter.

Institutional Moves

Institutional Moves (Q1 2026)

Neutral

Based on recent trading activity

Net Selling Institutions

83

Net Buying Institutions

71

Key Holders

View all 172 holding institutions

Quarterly Activity

Recent Activity

+$39.2M

Total Buy Value

$127.2M

Total Sell Value

New buy29
Trim56
Add42
Sold out27

71

Net Buyers

83

Net Sellers

Insider Trading (Form 4)

Form 144 Pre-Sale Notices

1

Filings (90d)

$62K

Total Est. Value

56K shares

Planned Shares

Last Filed 2026-06-29
FilerFiling DateEst. Value
Ostrowski Erik2026-06-29$62K

Form 144 is a planned sale notice, not an executed transaction. Form 144 Tracker

Beneficial Ownership (13D/13G)

No Schedule 13D/13G filings for this ticker

Material Events (8-K)

1

Filings (14d)

Data as of 2026-06-30

View all Form 8-K filings

FAQ

Who are the top institutional investors holding AKEBIA THERAPEUTICS INC (AKBA)?
Major stakeholders currently include BlackRock, Inc. ($26.0M), State Street CORP ($16.1M), Vanguard Capital Management LLC ($15.5M). Based on the latest 13F filings, there are a total of 172 tracked investment funds and institutions maintaining positions in AKBA.
What is the overall institutional sentiment toward AKBA recently?
Institutional sentiment appears Bearish (Net Selling). During the most recent reporting quarter, the stock experienced a net outflow of $48.7M, driven by 71 managers accumulating shares while 83 reduced their exposure.
Which institutions have been selling or reducing their AKBA positions?
In the latest period, 56 funds trimmed their holdings, and 27 managers completely exited their positions. The aggregate reported sell value was $127.2M.
Are there any notable investors adding AKBA to their portfolios?
Yes, buying activity remains notable. 29 institutions opened new positions in {ticker}, and 42 existing holders added to their shares. The total reported buy value for the quarter amounted to $39.2M.

Related Stocks